Connection

Denis Guttridge to Adenocarcinoma

Back to Details
This is a "connection" page, showing publications Denis Guttridge has written about Adenocarcinoma.
Denis Guttridge
Connection Strength
0.837
Adenocarcinoma
  1. NF-?B regulates GDF-15 to suppress macrophage surveillance during early tumor development. J Clin Invest. 2017 Oct 02; 127(10):3796-3809.
    View in: PubMed
    Score: 0.476
  2. Perioperative cytokine levels portend early death after pancreatectomy for ductal adenocarcinoma. J Surg Oncol. 2018 May; 117(6):1260-1266.
    View in: PubMed
    Score: 0.121
  3. Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. Cancer Res. 2011 Aug 01; 71(15):5101-10.
    View in: PubMed
    Score: 0.077
  4. Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo. Nutr Cancer. 2011; 63(5):749-62.
    View in: PubMed
    Score: 0.077
  5. Comparison of animal models for head and neck cancer cachexia. Laryngoscope. 2007 Dec; 117(12):2152-8.
    View in: PubMed
    Score: 0.060
  6. Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia. J Natl Cancer Inst. 2015 Dec; 107(12):djv274.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.